21
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.161
Exchange
XHKG - Hong Kong Exchange
1.1
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Mabpharm
Company Analysis
2181.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2181.HK financial analysis by Eyestock methodology
Valuation
2181.HK valuation using historical relative method
Statements
2181.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2181.HK dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Mabpharm`s Current ratio for the last twelve months ended 2024-06-30 is 1.1
